Actelion Announces Full Year 2004 Financial Results
24 févr. 2005 01h00 HE
|
Actelion Ltd.
ALLSCHWIL/BASEL, Switzerland, Feb. 24, 2005 (PRIMEZONE) -- Actelion Ltd (SWX:ATLN) today announced its financial results for the full year 2004. With total net revenue of CHF 471.9 million (FY 2003:...
Actelion Provides Update on Bosentan in Japan
18 févr. 2005 01h22 HE
|
Actelion Ltd.
ALLSCHWIL, Switzerland, Feb. 18 2005 (PRIMEZONE) -- Actelion Ltd (SWX:ATLN) (Other OTC:ALIOF) today announced that the Japanese Health Authority (MHLW) have informed the company that the upcoming...
Actelion Ltd -- Scientific Publication on Long-Term Bosentan Use in PPH
01 févr. 2005 01h23 HE
|
Actelion Ltd.
ALLSCHWIL, Switzerland, Feb. 1, 2005 (PRIMEZONE) -- Actelion Ltd (Other OTC:ALIOF) (SWX:ATLN) announced today the publication of the scientific paper evaluating disease outcome of patients with...
Actelion Initiates Phase IIb/III Program With Clazosentan
22 déc. 2004 01h00 HE
|
Actelion Ltd.
ALLSCHWIL, Switzerland, Dec. 22, 2004 (PRIMEZONE) -- Actelion Ltd (Other OTC:ALIOF) (SWX:ATLN) announced today it has initiated the comprehensive global Phase IIb/III development program for...
Zavesca Trial Continues in Late Onset Tay-Sachs Disease
21 déc. 2004 11h35 HE
|
Actelion Ltd.
ALLSCHWIL, Switzerland, Dec. 21, 2004 (PRIMEZONE) -- Actelion Ltd (Other OTC:ALIOF) (SWX:ATLN) announced today that the pivotal study evaluating safety and efficacy of miglustat (Zavesca(R)) in...
Scientific Publication of RAPIDS-1 Study with Bosentan
20 déc. 2004 11h35 HE
|
Actelion Ltd.
ALLSCHWIL, Switzerland, Dec. 20, 2004 (PRIMEZONE) -- Actelion Ltd (Other OTC:ALIOF) (SWX:ATLN) announced today the publication of the full results of the successful study with Tracleer(r) (bosentan)...
Actelion Stops Acute Heart Failure Study
06 nov. 2004 20h42 HE
|
Actelion Ltd.
ALLSCHWIL, Switzerland, Nov. 6, 2004 (PRIMEZONE) -- Actelion Ltd (SWX:ATLN) (Pink Sheets:ALIOF) today announced that the VERITAS study evaluating efficacy and safety of tezosentan in Acute Heart...
Actelion Announces 9-Month Results for 2004
26 oct. 2004 01h00 HE
|
Actelion Ltd.
ALLSCHWIL, Switzerland, Oct. 26, 2004 (PRIMEZONE) -- Actelion Ltd. (SWX:ATLN) today announced its financial result for the first nine months of 2004. With total net revenues for the first nine months...
Actelion Ltd.: New scientific studies show higher than expected prevalence of Pulmonary Arterial Hypertension in patients with Connective Tissue Diseases (CTD)
18 oct. 2004 01h10 HE
|
Actelion Ltd.
ALLSCHWIL, Swtzerland and SAN ANTONIO, Texas, Oct. 18, 2004 (PRIMEZONE) -- Actelion Ltd. (PinkSheets:ALIOF): Studies reported at the American College of Rheumatology (ACR) support early diagnostic...
Actelion announces half-year results 2004
27 juil. 2004 01h00 HE
|
Actelion Ltd.
ALLSCHWIL/BASEL, Switzerland, July 27, 2004 (PRIMEZONE) -- Actelion Ltd (SWX:ATLN) today announced its financial results for the first six months of 2004. With total net revenues for H1 2004 of CHF...